Alcohol and Tea Consumption in Relation to Liver Cancer Risk by Diabetes Status: A Prospective Cohort Study of 0.5 Million Chinese Adults
Nutrients · 2025
DOI: 10.3390/nu17172870 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nutrients, 2025. Verfasst von Xiaoru Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing 100084, China. Hauptthemen laut MEDLINE: Tea, Liver Neoplasms, Alcohol Drinking, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Natural Science Foundation of China, Beijing Nova Program.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Liver cancer is a significant disease burden, with metabolic factors potentially influencing its risk. Diabetics, due to metabolic abnormalities, may be more sensitive to environmental exposures. Beverages like tea and alcohol could impact liver cancer risk and may influence prevention in diabetics.
Methods
This study included 30,289 diabetics and 482,292 non-diabetics aged 30–79 years from the China Kadoorie Biobank. Baseline alcohol and tea consumption during the past year was collected through questionnaires, including frequency, amount, duration, and types. Incident liver cancer cases were identified from the national health insurance system and local disease registries. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
During a median follow-up of 9.6 years for diabetics and 10.1 years for non-diabetics, 193 (0.69 cases/1000 person-years) and 398 (0.45 cases/1000 person-years) incident liver cancer cases were documented, respectively. Weekly alcohol consumption was associated with higher liver cancer risk in both groups, stronger in diabetics (HR = 1.62; 95% CI: 1.12, 2.34) than in non-diabetics (HR = 1.20, 95% CI: 1.07, 1.35). Among diabetics, the risk was higher in some weekly alcohol consumption subgroups: high-level intake (HR = 2.21; 95% CI: 1.28, 3.80), ≥30 years (HR = 1.70; 95% CI: 1.06, 2.71), or spirit (≥50% alcohol) alcohol-specific consumption (HR = 1.91; 95% CI: 1.20, 3.04), and these associations were stronger than those in non-diabetics. For weekly tea consumption, low-level intake (HR = 0.82; 95% CI: 0.68, 0.99),
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
- School of Healthcare Management, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
- School of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
- School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
- Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
ORCID-Profile: Xiaoru Feng, Ruoqian Li, Minqing Yan, You Wu
Förderung
- Wellcome Trust
- National Natural Science Foundation of China
- Beijing Nova Program
- Chinese Ministry of Science and Technology
- Chinese National Natural Science Foundation
- Kadoorie Charitable Foundation
Zitieren
APA
Feng, X., Li, R., Yan, M., Yuan, C., & Wu, Y. (2025). Alcohol and Tea Consumption in Relation to Liver Cancer Risk by Diabetes Status: A Prospective Cohort Study of 0.5 Million Chinese Adults. Nutrients. https://doi.org/10.3390/nu17172870
Vancouver
Feng X, Li R, Yan M, Yuan C, Wu Y. Alcohol and Tea Consumption in Relation to Liver Cancer Risk by Diabetes Status: A Prospective Cohort Study of 0.5 Million Chinese Adults. Nutrients. 2025. doi:10.3390/nu17172870
BibTeX
@article{Feng2025,
author = {Feng, Xiaoru and Li, Ruoqian and Yan, Minqing and Yuan, Changzheng and Wu, You},
title = {Alcohol and Tea Consumption in Relation to Liver Cancer Risk by Diabetes Status: A Prospective Cohort Study of 0.5 Million Chinese Adults},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17172870}
}
EUVIMED